The bioavailability of phenylbutazone in the horse

References

• Allen L. M., Kimura K. K., MacKichan J. J., Ritschel W. A. Manual of symbols, equations and definitions in pharmacokinetics. Journal of Clinical Pharmacology 1982; 22: 1S–22S
   PubMedGoogle Scholar
• Argenzio R. A., Hintz H. F. Glucose tolerance and effect of volatile fatty acid on plasma glucose concentration in ponies. Journal of Animal Science 1970; 30: 514–518
   PubMedGoogle Scholar
• Barragry T. B. Phenylbutazone in equine practice—a review. Irish Veterinary Journal 1973; 27: 7–11
   Google Scholar
• Burns J. J., Rose R. K., Chenkin T., Goldman A., Schulert A., Brodie B. B. The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. Journal of Pharmacology and Experimental Therapeutics 1953; 109: 346–357
   PubMed Web of Science ®Google Scholar
• Cannon J. Phenylbutazone. Journal of the American Veterinary Medical Association 1974; 64: 367
   Google Scholar
• Currie J. P. Treatment of rheumatoid arthritis with butazolidine. Lancet 1952; ii: 15–16
   Google Scholar
• Eberhardson B., Olsson G., Appelgren L. E., Jacobsson S. E. Pharmacokinetic studies of phenylbutazone in cattle. Journal of Veterinary Pharmacology and Therapeutics 1979; 2: 31–37
   Google Scholar
• Gabel A. A., Tobin T. T., Ray R. S., Maylin G. A. Phenylbutazone in horses: A review. Journal of Equine Medicine and Surgery 1977; 1: 221–225
   Google Scholar
• Gandal C. P., Dayton P. G., Weiner M., Perel J. M. Studies with phenylbutazone, oxyphenbutazone and para-paradichlorophenylbutazone in horses. The Cornell Veterinarian 1969; 59: 577–580
   PubMedGoogle Scholar
• Gerring E. L., Lees P., Taylor J. B. Pharmacokinetics of phenylbutazone and its metabolites in the horse. Equine Veterinary Journal 1981; 13: 152–157
   PubMedGoogle Scholar
• Greenblatt D. J., Koch-Weser J. Clinical pharmacokinetics. The New England Journal of Medicine 1975; 291: 702–705
   Google Scholar
• Hintz H. F., Loy R. G. Effects of pelleting on the nutrititive value of horse rations. Journal of Animal Science 1966; 25: 1059–1061
   Google Scholar
• Jeffcott L. B., Colles C. M. Phenylbutazone and the horse—a review. Equine Veterinary Journal 1977; 9: 105–110
   PubMedGoogle Scholar
• Lees P., Maitho T. E., Millar J. D. Pharmacokinetics of phenylbutazone in Welsh mountain ponies. Proceedings of the Association for Veterinary Clinical Pharmacology and Therapeutics 1983; 7: 32–37
   Google Scholar
• Lees P., Ayliffe T. R., Higgins A. J., Maitho T. E., Sedgwick A. D., Taylor J. B. O. Pharmacokinetics and pharmacodynamics of phenylbutazone and related drugs in horses and cattle. Proceedings of the 3rd Congress of the European Association for Veterinary Pharmacology and Toxicology. 1985a, 147
   Google Scholar
• Lees P., Maitho T. E., Taylor J. B. Pharmacokinetics of phenylbutazone in two age groups of ponies: A preliminary study. The Veterinary Record 1985b; 116: 229–232
   PubMedGoogle Scholar
• Mackay R. J., French T. W., Nguyen H. T., Mayhew I. G. Effects of large doses of phenylbutazone administered to horses. American Journal of Veterinary Research 1983; 44: 774–780
   PubMedGoogle Scholar
• Marsh M. V. Characterisation of some metabolic conjugation pathways in the horse. University of London. 1983, Ph.D. Thesis
   Google Scholar
• Marsh M. V., Caldwell J., Smith R. L., Horner M. W., Houghton E., Moss M. S. Metabolic conjugation of some carboxylic acids in the horse. Xenobiotica 1981; 11: 655–663
   PubMedGoogle Scholar
• Moss M. S. Uses and misuses of anti-inflammatory drugs in racehorses—II. Equine Veterinary Journal 1972; 4: 69–73
   PubMedGoogle Scholar
• Moss M. S., Haywood P. E. Persistence of phenylbutazone in horses producing acid urines. The Veterinary Record 1973; 93: 124–126
   PubMedGoogle Scholar
• Piperno E., Ellis D. J., Getty S. M., Brody T. M. Plasma and urine levels of phenylbutazone in the horse. Journal of the American Veterinary Medical Association 1963; 153: 195–198
   Google Scholar
• Powis G., Snow D. H. The effects of exercise and adrenaline infusion upon the blood levels of antipyrine in the horse. The Journal of Pharmacology and Experimental Therapeutics 1978; 205: 725–731
   PubMedGoogle Scholar
• Rechenberg H. K. Phenylbutazone. Edward Arnold (Publishers) Ltd, London 1962
   Google Scholar
• Snow D. H., Douglas T. A., Thompson, II., Parkins J. J., Holmes P. H. Phenylbutazone toxicosis in equidae: A biochemical and pathophysiologic study. American Journal of Veterinary Research 1981; 42: 1754–1759
   PubMedGoogle Scholar
• Sullivan M., Snow D. H. Factors affecting absorption of non-steroidal anti-inflammatory agents in the horse. The Veterinary Record 1982; 110: 554–558
   PubMedGoogle Scholar
• Tobin T., Blake J. W., Valentine R. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oyyphenbutazone in phenylbutazone metabolism. American Journal of Veterinary Research 1977; 38: 123–127
   PubMedGoogle Scholar
• Triggs E. J., Nation R. L., Long A., Ashley J. J. Pharmacokinetics in the elderly. European Journal of Clinical Pharmacology 1975; 8: 55–62
   PubMed Web of Science ®Google Scholar
• Vander Noot G. W., Symons L. D., Lydman R. K., Fonnesbeck P. V. Rate of passage of various feedstuffs through the digestive tract of horses. Journal of Animal Science 1967; 36: 1309–1311
   Google Scholar
• Vesell E. F., Page J. G. Genetic control of drug levels in man: phenylbutazone. Science 1968; 159: 1479–1480
   PubMed Web of Science ®Google Scholar